I'm LongbridgeAI, I can summarize articles.The Estimates
Consensus has revenue at $698,000, up about 130% year on year from $298,000 and 22% above the second quarter's $570,000. POET Tech (POET.US) reports third-quarter fiscal 2026 results before the market opens on Monday, 16 November. EPS is seen at -$0.07, versus -$0.10 a year earlier. Gross margin is where the numbers change: consensus has 60% after quarters of 100%, so the accounting for mass-production costs decides that line. Press release only this quarter; calls start with the fourth quarter.
Track Record
Revenue rose for six straight quarters, from $167,000 in the first quarter of 2025 to $570,000 in the second quarter of 2026. Year on year, that is +112% and +202% respectively, on a base still under $1 million. Profits run the other way: the operating loss widened to $20.19 million from $8.76 million, while the net loss narrowed to $11.34 million from $17.26 million. Capacity and headcount are being booked ahead of volume. Cash and short-term investments stood at $796 million at the end of June, after $12.27 million of operating cash outflow in the quarter.
What to Watch
Start with guidance. Management targeted more than 30,000 optical engines for 2026, per late-August reports, and has not disclosed a shipment count. Any figure in the release is the cleanest read on the ramp. Lumilens follows: a $50 million initial order from mid-May, inside a five-year framework capped above $500 million. Samples were flagged for around the end of 2026, so revenue recognised this quarter and follow-on orders set the pricing. Cash is third: the $796 million came from a $400 million May raise, after guidance that wafer and optical engine assembly capacity would each expand about tenfold. Spending pace and any fresh raise set the dilution. Sector mood is the last variable. Optical communications names fell together on 5 November and this stock dropped 16%. CoreWeave's 11 November guidance lift bounced the group and the shares gained more than 10%. Price action tracks AI infrastructure sentiment more than company fundamentals.
Analyst Ratings
Coverage is thin and the targets disagree. MarketBeat's early-September tally found analysts leaning cautious, averaging $8.00; TipRanks' model was neutral on weak profitability and persistent cash burn. 24/7 Wall St. modelled $17.74 over 12 months in late August, on Malaysia ramping and Lumilens orders landing. Both sit above the 13 November close of $5.13. The split is over manufacturing execution and dilution pace.
In Short
This is a progress check, not a results comparison. Revenue is expected under $700,000. At $5.13 against end-June book value of $4.90 a share, the stock trades near 1.05x book, so most of the price is a 2027 volume assumption. Sustaining it needs progress on the 30,000 units, a visible path for Lumilens revenue, and cash burn that stays contained.
